ArriVent BioPharma, Inc.
AVBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868279
No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding ArriVent BioPharma, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 106 | 122 | +16 |
| Shares | 38.6M | 40.1M | +1.54M (+4.0%) |
| Value | $712.4M | $810.3M | +$97.9M (+13.7%) |
New holders (30)
Institutions that held ArriVent BioPharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (14)
Institutions that held ArriVent BioPharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Siren, L.L.C. | 700,000 | $12.9M |
| Cooperman Leon G | 421,278 | $7.77M |
| Franklin Resources Inc | 256,422 | $4.73M |
| CI Private Wealth, LLC | 33,500 | $618.1K |
| Corient IA LLC | 33,500 | $618.1K |
| Verition Fund Management LLC | 15,045 | $277.6K |
| Caption Management, LLC | 7,000 | $129.2K |
| Wexford Capital LP | 1,567 | $28.9K |
| Bessemer Group Inc | 1,395 | $26.0K |
| Parallel Advisors, LLC | 82 | $1.51K |
| Principal Securities, Inc. | 16 | $295 |
| Montag A & Associates Inc | 11 | $203 |
| Clearstead Advisors, LLC | 1 | $19 |
| IFP Advisors, Inc | 1 | $18 |